Skip to main content
SpringerLink
Log in

Inhibition of angiogenesis as a strategy for tumor growth control

  • Published:
Molecular and chemical neuropathology

Abstract

Angiogenesis is a complex sequence of events leading to the formation of new capillaries. Although essential to maturation and wound healing, most angiogenesis in the adult is associated with pathological events, such as the development of solid tumors. One approach to the inhibition of angiogenesis is the antagonism of basic fibroblast growth factor, a major angiogenic protein. Evidence is reviewed to suggest that inhibiting angiogenesis results in the suppression of tumor growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bagavandoss P. and Wilks J. W. (1990) Specific inhibition of endothelial cell proliferation by thrombospondin.Biochem. Biophys. Res. Commun. 170, 867–872.

    Article  CAS  Google Scholar 

  • Baird A. and Klagsburn M. (1991) The fibroblast growth factor family.Cancer Cells 3, 239–243.

    CAS  PubMed  Google Scholar 

  • Brem S. S., Zagzag D., Tsanaclis A. C., Gately S., Elkouby M., and Brien S. (1990) Inhibition of angiogenesis and tumor growth in the brain.Am. J. Pathol. 137, 1121–1142.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Folkman J. (1971) Tumor angiogenesis: therapeutic implications.New Engl. J. Med. 285, 1182–1186.

    Article  CAS  Google Scholar 

  • Folkman J. (1972) Anti-angiogenesis: new concept for therapy of solid tumors.Ann. Surg. 175, 409–416.

    Article  CAS  Google Scholar 

  • Folkman J. and Klagsbrun M. (1987) Angiogenic factors.Science 235, 442–447.

    Article  CAS  Google Scholar 

  • Folkman J. (1990a) What is the evidence that tumors are angiogenesis-dependent.J. Natl. Cancer Inst. 82, 4–6.

    Article  CAS  Google Scholar 

  • Folkman J. L. (1990b) The angiogenic activity of FGF and its possible clinical applications, inGrowth Factors: from Genes to Clinical Application (Sara, V. R., et al., eds.), Raven, New York.

    Google Scholar 

  • Gross J. L., Morrison R. S., Eidsvoog K., Herblin W. F., Kornblith P. L., and Dexter D. L. (1990) Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth.J. Neurosci. Res. 27, 689–696.

    Article  CAS  Google Scholar 

  • Gross J. L., Hertel D., Herblin W. F., Neville M. and Brem S. S. (1991) Inhibition of basic fibroblast growth factor-induced angiogenesis and glioma tumor growth in vivo in copper depleted rats.Proc. Amer. Assoc. Cancer Res. 32, 57.

    Google Scholar 

  • Gross J. L., Herblin W. F., Eidsvoog K., Horlick R., and Brem S. S. (in press) Tumor growth regulation by modulation of basic fibroblast growth factor, inAngiogenesis, (Steiner R. and Langer R., eds.), Karger, Basel.

  • Herblin W. F. and Gross J. L. (in press) High affinity sites for basic fibroblast growth factor in solid tumors are associated with the vasculature, inAngiogenesis, (Steiner R. and Langer, R., eds.) Karger, Basel.

  • Hori A., Sasada R., Matsutani E., Naito K., Sakura Y., Fujita T., and Kozai Y. (1991) Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor.Cancer Res. 51, 6180–6184.

    CAS  PubMed  Google Scholar 

  • Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., and Folkman J. (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth.Nature 348, 555–557.

    Article  CAS  Google Scholar 

  • La Rocca R. V., Stein C. A., Danesi R. and Myers C. E. (1990) Suramin, a novel antitumor compound.J. Steroid Biochem. Mol. Biol. 37, 893–898.

    Article  Google Scholar 

  • Maione T. E., Gray G. S., Petro J., Hunt A. J., Donner A. L., Baure S. I., Carson H. F., and Sharpe R. J. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.Science 247, 77–79.

    Article  CAS  Google Scholar 

  • Maione T. E., Gray G. S., Hunt A. J., and Sharpe R. J. (1991) Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity.Cancer Res. 51, 2077–2083.

    CAS  PubMed  Google Scholar 

  • Missirlis E., Karakiulakis G., and Maragoudakis M. E. (1990) Antitumor effect of GPA1734 in rat Walker carcinoma.Invest. New Drugs 8, 145–147.

    Article  CAS  Google Scholar 

  • Moses M. A. and Langer R. (1991) Inhibitors of angiogenesis.BioTechnology 9, 630–634.

    CAS  PubMed  Google Scholar 

  • Oikawa T., Hirotani K., Shimamura M., Ashino-Fuse H., and Iwaguchi T. (1989) Powerful antiangiogenic activity of herbimycin A.J. Antibiotics 42, 1202–1204.

    Article  CAS  Google Scholar 

  • Rifkin D. B. and Moscatelli D. (1989) Recent developments in the cell biology of basic fibroblast growth factor.J. Cell Biol. 109, 1–6.

    Article  CAS  Google Scholar 

  • Sakamoto N., Iwahana M., Tanaka N. G., and Osada Y. (1991) Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2.Cancer Res. 51, 903–906.

    CAS  PubMed  Google Scholar 

  • Sato Y., Abe M., and takaki R. (1990) Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells.Biochem. Biophys. Res. Commun. 172, 595–600.

    Article  CAS  Google Scholar 

  • Shibata K. and Sataumabayashi S. (1986) Chemical modification of herbimycin A.J. Antibiotics 39, 415–423.

    Article  CAS  Google Scholar 

  • Takahashi J. A., Fukumoto M., Kozai Y., Ito N., Oda Y., Kikuchi H., and Hatanaka M. (1991) Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human fibroblast growth factor.FEBS Lett. 288, 65–71.

    Article  CAS  Google Scholar 

  • Tamargo R. J., Bok R. A., and Brem H. (1991) Angiogenesis inhibition by minocylineCancer Res. 51, 672–675.

    CAS  PubMed  Google Scholar 

  • Taylor S. and Folkman J. (1982) Protamine is an inhibitor of angiogenesis.Nature 297, 307–312.

    Article  CAS  Google Scholar 

  • Vlodavsky I., Fuks Z., Ishai-Michaeli R., Bashkin P., Levi E., Korner G., Bar-Shavit R., and Klagsbrun M. (1991) Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis.J. Cell Biochem. 45, 167–176.

    Article  CAS  Google Scholar 

  • Wellstein A., Zugmaier G., Califano J. A., III, Paik S., and Lippman M. E. (1991) Tumor growth dependent on Kaposi’s sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate.J. Natl. Cancer Inst. 83, 716–720.

    Article  CAS  Google Scholar 

  • Woltering E. A., Barrie R., O’Dorisio T. M., Arce D., Ure T., Cramer A., Holmes D., Robertson J., and Fassler J. (1991) Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane.J. Surg. Res. 50, 245–251.

    Article  CAS  Google Scholar 

  • Yamashita T., Sakai M., Kawai Y., Aono M., and Takahashi K. (1989) A new activity of herbimycin A: Inhibition of angiogenesis.J. Antibiotics 42, 1015–1017.

    Article  CAS  Google Scholar 

  • Zalatnai A. and Schally A. V. (1989) Treatment of N-nitrosobis (2-oxopropyl) amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.Cancer Res. 49, 1810–1815.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular and Cancer Research, The Du Pont Merck Pharmaceutical Company, Wilmington, DE

    William F. Herblin & Janet L. Gross

Authors
  1. William F. Herblin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janet L. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herblin, W.F., Gross, J.L. Inhibition of angiogenesis as a strategy for tumor growth control. Molecular and Chemical Neuropathology 21, 329–336 (1994). https://doi.org/10.1007/BF02815359

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02815359

Index Entries

Search

Navigation